You've just added:

Our Impact

How we're advancing cures globally

188

Medicines in the making

66

Institutions supported

39

Companies launched

21

Medicines in the clinic

15

Licenses to pharma

What sets us apart

In addition to receiving funding, every scholar is paired with a results-oriented and mission-focused team from our Therapeutics Development Center. Teams consist of a project manager and experienced pharma and business development advisors with a track record of bringing new drugs to market.

Learn More

Making discoveries partner-ready

Our pipeline represents the best science coming out of academic laboratories. Projects are selected for their innovation and potential for clinical impact. Our team proactively moves them forward to commercial viability and clinical use.

See All Discoveries

Accelerating Scientific Breakthroughs

By concentrating philanthropic, scientific, and business development resources during the high-risk stages of drug development, Harrington ‘de-risks’ therapeutic candidates and positions them for further investment and commercialization.

Learn More

The Latest

See All News
Harrington Discovery Institute at University Hospitals and Case Western Reserve School of Medicine Open Call for 2025 Harrington-MSTP Scholar Award

Press Releases

Harrington Discovery Institute at University Hospitals and Case Western Reserve School of Medicine Open Call for 2025 Harrington-MSTP Scholar Award

Grant award provides MD/PhD candidates with funding and expertise to translate promising scientific discoveries into medicines

Continue Reading
Oxford-Harrington Rare Disease Centre to Host Symposium on Pioneering Research and Innovation in Rare Disease Treatments

Press Releases

Oxford-Harrington Rare Disease Centre to Host Symposium on Pioneering Research and Innovation in Rare Disease Treatments

The Symposium explores how cutting-edge research, innovative treatment strategies, and collaboration is driving the development of effective therapies for rare diseases.

Continue Reading
Oxford-Harrington Rare Disease Centre Appoints Influential UK Leader in Health Innovation Policy, Baroness Nicola Blackwood, to its Advisory Council

Press Releases

Oxford-Harrington Rare Disease Centre Appoints Influential UK Leader in Health Innovation Policy, Baroness Nicola Blackwood, to its Advisory Council

In her position on OHC’s Advisory Council, Baroness Blackwood will contribute to advancing OHC’s mission to drive life-changing discoveries in rare disease, with a particular focus on addressing critical unmet needs in the UK.

Continue Reading
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.